Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cannformatics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Cannformatics

Cannformatics

Seed

Cannformatics: Advancing health with predictable, science-based outcomes via saliva-based cannabis biomarkers.

HQ
San Francisco, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Cannformatics, founded with a mission to improve health and quality of life through science-based outcomes, is a biotechnology company specializing in the development of saliva-based Cannabis-Responsive™ biomarkers. Their core vision is to deliver predictable and repeatable results in medical cannabis treatments. Cannformatics focuses on leveraging these biomarkers to personalize medical cannabis treatments, particularly for conditions such as autism spectrum disorder (ASD).

Notable achievements include the publication of groundbreaking research in "Scientific Reports," highlighting their progress in personalizing medical cannabis treatments for children with ASD using machine learning approaches. The company has garnered attention for its innovative approach and potential impact on the medical cannabis industry. Key affiliated individuals and investors have not been specified, but the company's advancements position it as a significant player in the intersection of biotechnology and medical cannabis.

Cannformatics - Similar Companies

TreatmentX logo

TreatmentX

treatmentx.com

Gatc Canna logo

Gatc Canna

Cannabis Big Data logo

Cannabis Big Data

Hemp Synergistics logo

Hemp Synergistics

Potbotics logo

Potbotics

Greater Cannabis logo

Greater Cannabis

gcanrx.com

Next Frontier Biosciences logo

Next Frontier Biosciences

Cannacopia logo

Cannacopia

cannacopia.com

Outlier Biopharma logo

Outlier Biopharma

Harvest Direct Enterprises logo

Harvest Direct Enterprises

Agronomed Pharmaceuticals logo

Agronomed Pharmaceuticals

agronomed.com

Cannalysis logo

Cannalysis

cannalysislabs.com

Wellcana logo

Wellcana

Dogecoin Cash logo

Dogecoin Cash

cbds.com

The People's Ecosystem logo

The People's Ecosystem

Cannformatics - Quick Facts

Who are Cannformatics' competitors?

Companies similar to Cannformatics include TreatmentX, Gatc Canna, Cannabis Big Data and Hemp Synergistics.

When was Cannformatics founded?

Cannformatics was founded in 2017.

Where is Cannformatics' headquarters located?

Cannformatics' headquarters is located in San Francisco, CA, US.

When was Cannformatics' last funding round?

Cannformatics' most recent funding round was for $100k (USD) in August 2020.

How much has Cannformatics raised to-date?

As of Aug 5, 2020, Cannformatics has raised a total of $100k (USD).

How many employees does Cannformatics have?

Cannformatics has 6 employees as of Feb 4, 2024.

Cannformatics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biomarkers
  • Cannabis
Tags
  • Biotech
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 620000Health Care and Social Assistance